Survival and Readmission Burden in Advanced Heart Failure Patients Managed With Ventricular Assist Device Versus Continued Medical Therapy
Jeffrey D. Alexis(University of Rochester), Ilan Goldenberg, Anuradha Godishala, Anas Jawaid(Cardiovascular Research Center), Leway Chen(University of Rochester), Anita Y. Chen(University of Rochester Medicine), Scott McNitt(University of Rochester), Igor Gošev(Cardiovascular Research Center), Bronislava Polonsky(University of Rochester Medicine), Sabu Thomas(McMaster University), Katherine Wood(Cardiovascular Research Center), Mark Tallman(Cardiovascular Research Center), J. Martens(Cardiovascular Research Center)
Cited by 2
Related Papers
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
|Circulation|2009|1k
Myocardial Injury after Noncardiac Surgery
|Anesthesiology|2014|979
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
|Journal of the American College of Cardiology|2005|658
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
|New England Journal of Medicine|2016|597